Binder profile
ZINC3781867
Virtual-screening candidate from ZINC.
Bound to: PA5514 — beta-lactamase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3781867- UniProt (similar protein)
Q50H31- Tanimoto
- 1.000
- Target protein
- PA5514
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 300.3
- LogP ≤ 5 -1.52
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 122.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=OC[C@@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O
InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10-/m1/s1InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10-/m1/s1
LPQZKKCYTLCDGQ-KHQFGBGNSA-NLPQZKKCYTLCDGQ-KHQFGBGNSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- TAZ
- Homolog
- Q50H31
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3781867 →
- ZINC ZINC20 ZINC3781867 →
- UniProt UniProt Q50H31 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3781867”) →
Other binders for this protein
Quick navigation to other ligands bound to PA5514.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 48
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).